Last edition
News about Biotechnology
Novo Nordisk Signs USD 2.1 Billion Pact with Vivtex to Develop Oral Obesity Therapies
Novo Nordisk has entered into a strategic collaboration with US-based Vivtex to develop next-generation oral biologic therapies for obesity, diabetes and related metabolic conditions.
Biotechnology | 27/02/2026 | By Darshana | 135
AS76 Brings Edge AI to Diagnostic Microscopy with On-Device High-Throughput Analysis
SigTuple has launched AS76, an AI-enabled digital morphology analyser designed to automate peripheral blood smear (PBS) microscopic review. The system integrates automated digital microscopy with on-device edge AI computing to deliver faster, standardized results while maintaining strict data privacy.
Biotechnology | 26/02/2026 | By Darshana | 124
IBA and Shreeji Sign Multi-Site Deal to Deploy Four Cyclotrons Across India
Ion Beam Applications S.A. (IBA), a global leader in particle accelerator technology and nuclear medicine solutions, has signed a multi-site agreement with Shreeji Imaging and Diagnostic Centre Pvt. Ltd. for the delivery and installation of four Cyclone KIUBE 300 cyclotrons in India.
Biotechnology | 21/02/2026 | By Darshana | 221
Newron Strengthens Clinical Development Funding with Multi-Tranche Share Deal
Newron Pharmaceuticals has secured a staged equity financing agreement worth up to EUR 38 million from a consortium of existing and new investors in Europe and Asia, strengthening its balance sheet as it advances late-stage clinical development of evenamide for treatment-resistant schizophrenia.
Biotechnology | 18/02/2026 | By Darshana | 162
Bio-Techne Corporation has received CE-IVD marking for its Ella benchtop immunoassay platform, enabling commercial availability across the European Union and opening new opportunities for clinical diagnostic use.
Biotechnology | 17/02/2026 | By Darshana | 141
Median Technologies, a France-based developer of artificial intelligence-powered software as a medical device, has entered a non-exclusive distribution agreement with Tempus AI, Inc. to commercialise its Eyonis LCS lung screening platform in the United States.
Biotechnology | 15/02/2026 | By Darshana | 292
THX Pharma and Biocodex Sign Licensing Deal for Rare Disease Drug Candidates
Biocodex secures global rights to Batten-1 and North American rights to TX01 from THX Pharma in a deal worth up to Euro 173 million to advance treatments for juvenile Batten disease, Gaucher disease and Niemann-Pick type C.
Biotechnology | 13/02/2026 | By News Bureau | 198
Fujifilm Opens GBP 400 Million UK Biomanufacturing Expansion
Backed by an investment of approximately GBP 400 million from Fujifilm Corporation, the development includes the launch of what the company describes as the UK’s largest single-use biopharmaceutical contract development and manufacturing facility.
Biotechnology | 12/02/2026 | By Darshana | 157
NPPA Directs Drugmakers to Revise MRPs After 2026 Duty Exemptions
The National Pharmaceutical Pricing Authority (NPPA) has directed drug manufacturers to revise the maximum retail prices (MRP) of medicines that received customs duty exemptions under the Union Budget 2026.
Biotechnology | 12/02/2026 | By Darshana | 328
Chugai Exercises Option for AraLinQ Technology in USD 780 Million ADC Collaboration
Chugai Pharmaceutical Co., Ltd. has exercised its option to license Araris Biotech AG’s proprietary AraLinQ linker-payload platform, deepening an existing research collaboration aimed at developing next-generation antibody-drug conjugates (ADCs).
Biotechnology | 11/02/2026 | By Darshana | 209
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy